Context Therapeutics Inc. (CNTX) vs Seres Therapeutics, Inc. (MCRB)

Context Therapeutics Inc. and Seres Therapeutics, Inc. are both Biotechnology companies. Context Therapeutics Inc. and Seres Therapeutics, Inc. are of similar size ($36.0M and $34.1M). Context Therapeutics Inc. has the higher net margin (0.00% vs −1,192.9%) and the higher return on invested capital (0.00% vs −277.3%). Across the 13 metrics below, Context Therapeutics Inc. leads on 8 and Seres Therapeutics, Inc. on 5.

Valuation

Metric CNTX MCRB Biotechnology median
P/E n/m n/m 7.88
P/S n/m 18.14 11.47
P/B 0.87 0.99 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.20 n/m 0.74
EV/Sales n/m 64.29 10.73
Earnings yield (137.14%) (69.03%) (28.84%)
Free cash flow yield (102.14%) (150.01%) (23.03%)

Profitability

Metric CNTX MCRB Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% (4,462.77%) 0.00%
Net margin 0.00% (1,192.94%) 0.00%
Free cash flow margin 0.00% (2,721.83%) 0.00%
Return on equity (76.14%) (66.57%) (57.72%)
Return on assets (68.96%) (18.31%) (49.22%)
Return on invested capital 0.00% (277.30%) 0.00%

Growth

Metric CNTX MCRB Biotechnology median
Revenue growth (TTM) — (98.51%) 5.64%
EPS growth (last fiscal year) 17.39% 0.00% —
Revenue growth, 5-year CAGR — (53.03%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CNTX MCRB Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.81 2.11 4.73
Net debt to EBITDA 1.66 0.51 0.96

Dividend

Metric CNTX MCRB Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric CNTX MCRB Biotechnology median
Market cap 34.10m 35.99m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack